Advertisement

Index by author

September 01, 2014; Volume 42,Issue 9

A

  1. Abdel-Razzak, Ziad

    1. Impact of Inflammation on Chlorpromazine-Induced Cytotoxicity and Cholestatic Features in HepaRG Cells
      Pamela Bachour-El Azzi, Ahmad Sharanek, Ziad Abdel-Razzak, Sebastien Antherieu, Houssein Al-Attrache, Camille C. Savary, Sylvie Lepage, Isabelle Morel, Gilles Labbe, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition September 2014, 42 (9) 1556-1566; DOI: https://doi.org/10.1124/dmd.114.058123

  2. Abduljalil, Khaled

    1. Deciding on Success Criteria for Predictability of Pharmacokinetic Parameters from In Vitro Studies: An Analysis Based on In Vivo Observations
      Khaled Abduljalil, Theresa Cain, Helen Humphries and Amin Rostami-Hodjegan
      Drug Metabolism and Disposition September 2014, 42 (9) 1478-1484; DOI: https://doi.org/10.1124/dmd.114.058099

  3. Ahn, Taeho

    1. Regioselective Hydroxylation of Omeprazole Enantiomers by Bacterial CYP102A1 Mutants
      Sang Hoon Ryu, Bo-Yeon Park, So-Young Kim, Sun-Ha Park, Hyun-Jin Jung, Min Park, Ki Deok Park, Taeho Ahn, Hyung-Sik Kang and Chul-Ho Yun
      Drug Metabolism and Disposition September 2014, 42 (9) 1493-1497; DOI: https://doi.org/10.1124/dmd.114.058636

  4. Al-Attrache, Houssein

    1. Impact of Inflammation on Chlorpromazine-Induced Cytotoxicity and Cholestatic Features in HepaRG Cells
      Pamela Bachour-El Azzi, Ahmad Sharanek, Ziad Abdel-Razzak, Sebastien Antherieu, Houssein Al-Attrache, Camille C. Savary, Sylvie Lepage, Isabelle Morel, Gilles Labbe, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition September 2014, 42 (9) 1556-1566; DOI: https://doi.org/10.1124/dmd.114.058123

  5. An, Guohua

    1. Flavonoids Are Inhibitors of Human Organic Anion Transporter 1 (OAT1)–Mediated Transport
      Guohua An, Xiaodong Wang and Marilyn E. Morris
      Drug Metabolism and Disposition September 2014, 42 (9) 1357-1366; DOI: https://doi.org/10.1124/dmd.114.059337

  6. Andersson, Tommy B.

    1. Long-Term Chronic Toxicity Testing Using Human Pluripotent Stem Cell–Derived Hepatocytes
      Gustav Holmgren, Anna-Karin Sjögren, Isabel Barragan, Alan Sabirsh, Peter Sartipy, Jane Synnergren, Petter Björquist, Magnus Ingelman-Sundberg, Tommy B. Andersson and Josefina Edsbagge
      Drug Metabolism and Disposition September 2014, 42 (9) 1401-1406; DOI: https://doi.org/10.1124/dmd.114.059154

  7. Antherieu, Sebastien

    1. Impact of Inflammation on Chlorpromazine-Induced Cytotoxicity and Cholestatic Features in HepaRG Cells
      Pamela Bachour-El Azzi, Ahmad Sharanek, Ziad Abdel-Razzak, Sebastien Antherieu, Houssein Al-Attrache, Camille C. Savary, Sylvie Lepage, Isabelle Morel, Gilles Labbe, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition September 2014, 42 (9) 1556-1566; DOI: https://doi.org/10.1124/dmd.114.058123

  8. Argikar, Upendra A.

    1. A Numerical Method for Analysis of In Vitro Time-Dependent Inhibition Data. Part 2. Application to Experimental Data
      Ken Korzekwa, Donald Tweedie, Upendra A. Argikar, Andrea Whitcher-Johnstone, Leslie Bell, Shari Bickford and Swati Nagar
      Drug Metabolism and Disposition September 2014, 42 (9) 1587-1595; DOI: https://doi.org/10.1124/dmd.114.058297

  9. Avian, Alexander

    1. Inflammatory Bowel Disease Alters Intestinal Bile Acid Transporter Expression
      Jörg Jahnel, Peter Fickert, Almuthe C. Hauer, Christoph Högenauer, Alexander Avian and Michael Trauner
      Drug Metabolism and Disposition September 2014, 42 (9) 1423-1431; DOI: https://doi.org/10.1124/dmd.114.058065

B

  1. Bachour-El Azzi, Pamela

    1. Impact of Inflammation on Chlorpromazine-Induced Cytotoxicity and Cholestatic Features in HepaRG Cells
      Pamela Bachour-El Azzi, Ahmad Sharanek, Ziad Abdel-Razzak, Sebastien Antherieu, Houssein Al-Attrache, Camille C. Savary, Sylvie Lepage, Isabelle Morel, Gilles Labbe, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition September 2014, 42 (9) 1556-1566; DOI: https://doi.org/10.1124/dmd.114.058123

  2. Bader, Urs

    1. Calibration of In Vitro Multidrug Resistance Protein 1 Substrate and Inhibition Assays as a Basis to Support the Prediction of Clinically Relevant Interactions In Vivo
      Agnès Poirier, Anne-Christine Cascais, Urs Bader, Renée Portmann, Marie-Elise Brun, Isabelle Walter, Alexander Hillebrecht, Mohammed Ullah and Christoph Funk
      Drug Metabolism and Disposition September 2014, 42 (9) 1411-1422; DOI: https://doi.org/10.1124/dmd.114.057943
    2. The Need for Human Breast Cancer Resistance Protein Substrate and Inhibition Evaluation in Drug Discovery and Development: Why, When, and How?
      Agnès Poirier, Renée Portmann, Anne-Christine Cascais, Urs Bader, Isabelle Walter, Mohammed Ullah and Christoph Funk
      Drug Metabolism and Disposition September 2014, 42 (9) 1466-1477; DOI: https://doi.org/10.1124/dmd.114.058248

  3. Barbero, Luca

    1. Time- and NADPH-Dependent Inhibition of Cytochrome P450 3A4 by the Cyclopentapeptide Cilengitide: Significance of the Guanidine Group and Accompanying Spectral Changes
      Mirza Bojić, Luca Barbero, Hugues Dolgos, Achim Freisleben, Dieter Gallemann, Simona Riva and F. Peter Guengerich
      Drug Metabolism and Disposition September 2014, 42 (9) 1438-1446; DOI: https://doi.org/10.1124/dmd.114.059295

  4. Barragan, Isabel

    1. Long-Term Chronic Toxicity Testing Using Human Pluripotent Stem Cell–Derived Hepatocytes
      Gustav Holmgren, Anna-Karin Sjögren, Isabel Barragan, Alan Sabirsh, Peter Sartipy, Jane Synnergren, Petter Björquist, Magnus Ingelman-Sundberg, Tommy B. Andersson and Josefina Edsbagge
      Drug Metabolism and Disposition September 2014, 42 (9) 1401-1406; DOI: https://doi.org/10.1124/dmd.114.059154

  5. Bell, Leslie

    1. A Numerical Method for Analysis of In Vitro Time-Dependent Inhibition Data. Part 2. Application to Experimental Data
      Ken Korzekwa, Donald Tweedie, Upendra A. Argikar, Andrea Whitcher-Johnstone, Leslie Bell, Shari Bickford and Swati Nagar
      Drug Metabolism and Disposition September 2014, 42 (9) 1587-1595; DOI: https://doi.org/10.1124/dmd.114.058297

  6. Bi, Huichang

    1. Dynamic and Coordinated Regulation of KEAP1-NRF2-ARE and p53/p21 Signaling Pathways Is Associated with Acetaminophen Injury Responsive Liver Regeneration
      Xiaomei Fan, Pan Chen, Huasen Tan, Hang Zeng, Yiming Jiang, Ying Wang, Yongtao Wang, Xiangyu Hou, Huichang Bi and Min Huang
      Drug Metabolism and Disposition September 2014, 42 (9) 1532-1539; DOI: https://doi.org/10.1124/dmd.114.059394

  7. Bickford, Shari

    1. A Numerical Method for Analysis of In Vitro Time-Dependent Inhibition Data. Part 2. Application to Experimental Data
      Ken Korzekwa, Donald Tweedie, Upendra A. Argikar, Andrea Whitcher-Johnstone, Leslie Bell, Shari Bickford and Swati Nagar
      Drug Metabolism and Disposition September 2014, 42 (9) 1587-1595; DOI: https://doi.org/10.1124/dmd.114.058297

  8. Björquist, Petter

    1. Long-Term Chronic Toxicity Testing Using Human Pluripotent Stem Cell–Derived Hepatocytes
      Gustav Holmgren, Anna-Karin Sjögren, Isabel Barragan, Alan Sabirsh, Peter Sartipy, Jane Synnergren, Petter Björquist, Magnus Ingelman-Sundberg, Tommy B. Andersson and Josefina Edsbagge
      Drug Metabolism and Disposition September 2014, 42 (9) 1401-1406; DOI: https://doi.org/10.1124/dmd.114.059154

  9. Bojić, Mirza

    1. Time- and NADPH-Dependent Inhibition of Cytochrome P450 3A4 by the Cyclopentapeptide Cilengitide: Significance of the Guanidine Group and Accompanying Spectral Changes
      Mirza Bojić, Luca Barbero, Hugues Dolgos, Achim Freisleben, Dieter Gallemann, Simona Riva and F. Peter Guengerich
      Drug Metabolism and Disposition September 2014, 42 (9) 1438-1446; DOI: https://doi.org/10.1124/dmd.114.059295

  10. Bratton, Stacie M.

    1. A Potential Role for Human UDP-Glucuronosyltransferase 1A4 Promoter Single Nucleotide Polymorphisms in the Pharmacogenomics of Tamoxifen and Its Derivatives
      Aleksandra K. Greer, Centdrika R. Dates, Athena Starlard-Davenport, Vineetha K. Edavana, Stacie M. Bratton, Ishwori B. Dhakal, Moshe Finel, Susan A. Kadlubar and Anna Radominska-Pandya
      Drug Metabolism and Disposition September 2014, 42 (9) 1392-1400; DOI: https://doi.org/10.1124/dmd.114.058016

  11. Bridges, Arlene S.

    1. Role of Multidrug Resistance–Associated Protein 4 in the Basolateral Efflux of Hepatically Derived Enalaprilat
      Brian C. Ferslew, Kathleen Köck, Arlene S. Bridges and Kim L. R. Brouwer
      Drug Metabolism and Disposition September 2014, 42 (9) 1567-1574; DOI: https://doi.org/10.1124/dmd.114.057554

  12. Brouwer, Kim L. R.

    1. Role of Multidrug Resistance–Associated Protein 4 in the Basolateral Efflux of Hepatically Derived Enalaprilat
      Brian C. Ferslew, Kathleen Köck, Arlene S. Bridges and Kim L. R. Brouwer
      Drug Metabolism and Disposition September 2014, 42 (9) 1567-1574; DOI: https://doi.org/10.1124/dmd.114.057554

  13. Brun, Marie-Elise

    1. Calibration of In Vitro Multidrug Resistance Protein 1 Substrate and Inhibition Assays as a Basis to Support the Prediction of Clinically Relevant Interactions In Vivo
      Agnès Poirier, Anne-Christine Cascais, Urs Bader, Renée Portmann, Marie-Elise Brun, Isabelle Walter, Alexander Hillebrecht, Mohammed Ullah and Christoph Funk
      Drug Metabolism and Disposition September 2014, 42 (9) 1411-1422; DOI: https://doi.org/10.1124/dmd.114.057943

C

  1. Cain, Theresa

    1. Deciding on Success Criteria for Predictability of Pharmacokinetic Parameters from In Vitro Studies: An Analysis Based on In Vivo Observations
      Khaled Abduljalil, Theresa Cain, Helen Humphries and Amin Rostami-Hodjegan
      Drug Metabolism and Disposition September 2014, 42 (9) 1478-1484; DOI: https://doi.org/10.1124/dmd.114.058099

  2. Callendrello, Alanna L.

    1. Evaluation of Calibration Curve–Based Approaches to Predict Clinical Inducers and Noninducers of CYP3A4 with Plated Human Hepatocytes
      J. George Zhang, Thuy Ho, Alanna L. Callendrello, Robert J. Clark, Elizabeth A. Santone, Sarah Kinsman, Deqing Xiao, Lisa G. Fox, Heidi J. Einolf and David M. Stresser
      Drug Metabolism and Disposition September 2014, 42 (9) 1379-1391; DOI: https://doi.org/10.1124/dmd.114.058602

  3. Camenisch, Gian

    1. Prediction of Organic Anion-Transporting Polypeptide 1B1- and 1B3-Mediated Hepatic Uptake of Statins Based on Transporter Protein Expression and Activity Data
      Annett Kunze, Jörg Huwyler, Gian Camenisch and Birk Poller
      Drug Metabolism and Disposition September 2014, 42 (9) 1514-1521; DOI: https://doi.org/10.1124/dmd.114.058412

  4. Cascais, Anne-Christine

    1. Calibration of In Vitro Multidrug Resistance Protein 1 Substrate and Inhibition Assays as a Basis to Support the Prediction of Clinically Relevant Interactions In Vivo
      Agnès Poirier, Anne-Christine Cascais, Urs Bader, Renée Portmann, Marie-Elise Brun, Isabelle Walter, Alexander Hillebrecht, Mohammed Ullah and Christoph Funk
      Drug Metabolism and Disposition September 2014, 42 (9) 1411-1422; DOI: https://doi.org/10.1124/dmd.114.057943
    2. The Need for Human Breast Cancer Resistance Protein Substrate and Inhibition Evaluation in Drug Discovery and Development: Why, When, and How?
      Agnès Poirier, Renée Portmann, Anne-Christine Cascais, Urs Bader, Isabelle Walter, Mohammed Ullah and Christoph Funk
      Drug Metabolism and Disposition September 2014, 42 (9) 1466-1477; DOI: https://doi.org/10.1124/dmd.114.058248

  5. Chen, Pan

    1. Dynamic and Coordinated Regulation of KEAP1-NRF2-ARE and p53/p21 Signaling Pathways Is Associated with Acetaminophen Injury Responsive Liver Regeneration
      Xiaomei Fan, Pan Chen, Huasen Tan, Hang Zeng, Yiming Jiang, Ying Wang, Yongtao Wang, Xiangyu Hou, Huichang Bi and Min Huang
      Drug Metabolism and Disposition September 2014, 42 (9) 1532-1539; DOI: https://doi.org/10.1124/dmd.114.059394

  6. Chiba, Masato

    1. Effect of CYP2A6 Genetic Polymorphism on the Metabolic Conversion of Tegafur to 5-Fluorouracil and Its Enantioselectivity
      Ikuo Yamamiya, Kunihiro Yoshisue, Yuji Ishii, Hideyuki Yamada and Masato Chiba
      Drug Metabolism and Disposition September 2014, 42 (9) 1485-1492; DOI: https://doi.org/10.1124/dmd.114.058008
    2. Interindividual Variations in Metabolism and Pharmacokinetics of 3-(6-Methylpyridine-3-yl-sulfanyl)-6-(4H-[1,2,4]triazole-3-yl-sulfanyl)-N-(1,3-thiazole-2-yl)-2-pyridine carboxamide, a Glucokinase Activator, in Rats Caused by the Genetic Polymorphism of CYP2D1
      Takuro Hasegawa, Jun-ichi Eiki and Masato Chiba
      Drug Metabolism and Disposition September 2014, 42 (9) 1548-1555; DOI: https://doi.org/10.1124/dmd.114.058081

  7. Clark, Robert J.

    1. Evaluation of Calibration Curve–Based Approaches to Predict Clinical Inducers and Noninducers of CYP3A4 with Plated Human Hepatocytes
      J. George Zhang, Thuy Ho, Alanna L. Callendrello, Robert J. Clark, Elizabeth A. Santone, Sarah Kinsman, Deqing Xiao, Lisa G. Fox, Heidi J. Einolf and David M. Stresser
      Drug Metabolism and Disposition September 2014, 42 (9) 1379-1391; DOI: https://doi.org/10.1124/dmd.114.058602

  8. Craig, Evelyn L.

    1. Nicotine Pharmacokinetics in Rats Is Altered as a Function of Age, Impacting the Interpretation of Animal Model Data
      Evelyn L. Craig, Bin Zhao, Jason Z. Cui, Maria Novalen, Sharon Miksys and Rachel F. Tyndale
      Drug Metabolism and Disposition September 2014, 42 (9) 1447-1455; DOI: https://doi.org/10.1124/dmd.114.058719

  9. Cui, Jason Z.

    1. Nicotine Pharmacokinetics in Rats Is Altered as a Function of Age, Impacting the Interpretation of Animal Model Data
      Evelyn L. Craig, Bin Zhao, Jason Z. Cui, Maria Novalen, Sharon Miksys and Rachel F. Tyndale
      Drug Metabolism and Disposition September 2014, 42 (9) 1447-1455; DOI: https://doi.org/10.1124/dmd.114.058719

D

  1. Danhof, Meindert

    1. Translational Pharmacokinetic Modeling of Fingolimod (FTY720) as a Paradigm Compound Subject to Sphingosine Kinase-Mediated Phosphorylation
      Nelleke Snelder, Bart A. Ploeger, Olivier Luttringer, Donald. R. Stanski and Meindert Danhof
      Drug Metabolism and Disposition September 2014, 42 (9) 1367-1378; DOI: https://doi.org/10.1124/dmd.113.056770

  2. Dates, Centdrika R.

    1. A Potential Role for Human UDP-Glucuronosyltransferase 1A4 Promoter Single Nucleotide Polymorphisms in the Pharmacogenomics of Tamoxifen and Its Derivatives
      Aleksandra K. Greer, Centdrika R. Dates, Athena Starlard-Davenport, Vineetha K. Edavana, Stacie M. Bratton, Ishwori B. Dhakal, Moshe Finel, Susan A. Kadlubar and Anna Radominska-Pandya
      Drug Metabolism and Disposition September 2014, 42 (9) 1392-1400; DOI: https://doi.org/10.1124/dmd.114.058016

  3. Dhakal, Ishwori B.

    1. A Potential Role for Human UDP-Glucuronosyltransferase 1A4 Promoter Single Nucleotide Polymorphisms in the Pharmacogenomics of Tamoxifen and Its Derivatives
      Aleksandra K. Greer, Centdrika R. Dates, Athena Starlard-Davenport, Vineetha K. Edavana, Stacie M. Bratton, Ishwori B. Dhakal, Moshe Finel, Susan A. Kadlubar and Anna Radominska-Pandya
      Drug Metabolism and Disposition September 2014, 42 (9) 1392-1400; DOI: https://doi.org/10.1124/dmd.114.058016

  4. Dolgos, Hugues

    1. Time- and NADPH-Dependent Inhibition of Cytochrome P450 3A4 by the Cyclopentapeptide Cilengitide: Significance of the Guanidine Group and Accompanying Spectral Changes
      Mirza Bojić, Luca Barbero, Hugues Dolgos, Achim Freisleben, Dieter Gallemann, Simona Riva and F. Peter Guengerich
      Drug Metabolism and Disposition September 2014, 42 (9) 1438-1446; DOI: https://doi.org/10.1124/dmd.114.059295

E

  1. Edavana, Vineetha K.

    1. A Potential Role for Human UDP-Glucuronosyltransferase 1A4 Promoter Single Nucleotide Polymorphisms in the Pharmacogenomics of Tamoxifen and Its Derivatives
      Aleksandra K. Greer, Centdrika R. Dates, Athena Starlard-Davenport, Vineetha K. Edavana, Stacie M. Bratton, Ishwori B. Dhakal, Moshe Finel, Susan A. Kadlubar and Anna Radominska-Pandya
      Drug Metabolism and Disposition September 2014, 42 (9) 1392-1400; DOI: https://doi.org/10.1124/dmd.114.058016

  2. Edsbagge, Josefina

    1. Long-Term Chronic Toxicity Testing Using Human Pluripotent Stem Cell–Derived Hepatocytes
      Gustav Holmgren, Anna-Karin Sjögren, Isabel Barragan, Alan Sabirsh, Peter Sartipy, Jane Synnergren, Petter Björquist, Magnus Ingelman-Sundberg, Tommy B. Andersson and Josefina Edsbagge
      Drug Metabolism and Disposition September 2014, 42 (9) 1401-1406; DOI: https://doi.org/10.1124/dmd.114.059154

  3. Eiki, Jun-ichi

    1. Interindividual Variations in Metabolism and Pharmacokinetics of 3-(6-Methylpyridine-3-yl-sulfanyl)-6-(4H-[1,2,4]triazole-3-yl-sulfanyl)-N-(1,3-thiazole-2-yl)-2-pyridine carboxamide, a Glucokinase Activator, in Rats Caused by the Genetic Polymorphism of CYP2D1
      Takuro Hasegawa, Jun-ichi Eiki and Masato Chiba
      Drug Metabolism and Disposition September 2014, 42 (9) 1548-1555; DOI: https://doi.org/10.1124/dmd.114.058081

  4. Einolf, Heidi J.

    1. Evaluation of Calibration Curve–Based Approaches to Predict Clinical Inducers and Noninducers of CYP3A4 with Plated Human Hepatocytes
      J. George Zhang, Thuy Ho, Alanna L. Callendrello, Robert J. Clark, Elizabeth A. Santone, Sarah Kinsman, Deqing Xiao, Lisa G. Fox, Heidi J. Einolf and David M. Stresser
      Drug Metabolism and Disposition September 2014, 42 (9) 1379-1391; DOI: https://doi.org/10.1124/dmd.114.058602

  5. El-Kadi, Ayman O.S.

    1. Characterization of Arachidonic Acid Metabolism by Rat Cytochrome P450 Enzymes: The Involvement of CYP1As
      Ahmed A. El-Sherbeni and Ayman O.S. El-Kadi
      Drug Metabolism and Disposition September 2014, 42 (9) 1498-1507; DOI: https://doi.org/10.1124/dmd.114.057836

  6. El-Sherbeni, Ahmed A.

    1. Characterization of Arachidonic Acid Metabolism by Rat Cytochrome P450 Enzymes: The Involvement of CYP1As
      Ahmed A. El-Sherbeni and Ayman O.S. El-Kadi
      Drug Metabolism and Disposition September 2014, 42 (9) 1498-1507; DOI: https://doi.org/10.1124/dmd.114.057836

F

  1. Fan, Xiaomei

    1. Dynamic and Coordinated Regulation of KEAP1-NRF2-ARE and p53/p21 Signaling Pathways Is Associated with Acetaminophen Injury Responsive Liver Regeneration
      Xiaomei Fan, Pan Chen, Huasen Tan, Hang Zeng, Yiming Jiang, Ying Wang, Yongtao Wang, Xiangyu Hou, Huichang Bi and Min Huang
      Drug Metabolism and Disposition September 2014, 42 (9) 1532-1539; DOI: https://doi.org/10.1124/dmd.114.059394

  2. Ferslew, Brian C.

    1. Role of Multidrug Resistance–Associated Protein 4 in the Basolateral Efflux of Hepatically Derived Enalaprilat
      Brian C. Ferslew, Kathleen Köck, Arlene S. Bridges and Kim L. R. Brouwer
      Drug Metabolism and Disposition September 2014, 42 (9) 1567-1574; DOI: https://doi.org/10.1124/dmd.114.057554

  3. Fickert, Peter

    1. Inflammatory Bowel Disease Alters Intestinal Bile Acid Transporter Expression
      Jörg Jahnel, Peter Fickert, Almuthe C. Hauer, Christoph Högenauer, Alexander Avian and Michael Trauner
      Drug Metabolism and Disposition September 2014, 42 (9) 1423-1431; DOI: https://doi.org/10.1124/dmd.114.058065

  4. Finel, Moshe

    1. A Potential Role for Human UDP-Glucuronosyltransferase 1A4 Promoter Single Nucleotide Polymorphisms in the Pharmacogenomics of Tamoxifen and Its Derivatives
      Aleksandra K. Greer, Centdrika R. Dates, Athena Starlard-Davenport, Vineetha K. Edavana, Stacie M. Bratton, Ishwori B. Dhakal, Moshe Finel, Susan A. Kadlubar and Anna Radominska-Pandya
      Drug Metabolism and Disposition September 2014, 42 (9) 1392-1400; DOI: https://doi.org/10.1124/dmd.114.058016

  5. Fox, Lisa G.

    1. Evaluation of Calibration Curve–Based Approaches to Predict Clinical Inducers and Noninducers of CYP3A4 with Plated Human Hepatocytes
      J. George Zhang, Thuy Ho, Alanna L. Callendrello, Robert J. Clark, Elizabeth A. Santone, Sarah Kinsman, Deqing Xiao, Lisa G. Fox, Heidi J. Einolf and David M. Stresser
      Drug Metabolism and Disposition September 2014, 42 (9) 1379-1391; DOI: https://doi.org/10.1124/dmd.114.058602

  6. Freisleben, Achim

    1. Time- and NADPH-Dependent Inhibition of Cytochrome P450 3A4 by the Cyclopentapeptide Cilengitide: Significance of the Guanidine Group and Accompanying Spectral Changes
      Mirza Bojić, Luca Barbero, Hugues Dolgos, Achim Freisleben, Dieter Gallemann, Simona Riva and F. Peter Guengerich
      Drug Metabolism and Disposition September 2014, 42 (9) 1438-1446; DOI: https://doi.org/10.1124/dmd.114.059295

  7. Funk, Christoph

    1. Calibration of In Vitro Multidrug Resistance Protein 1 Substrate and Inhibition Assays as a Basis to Support the Prediction of Clinically Relevant Interactions In Vivo
      Agnès Poirier, Anne-Christine Cascais, Urs Bader, Renée Portmann, Marie-Elise Brun, Isabelle Walter, Alexander Hillebrecht, Mohammed Ullah and Christoph Funk
      Drug Metabolism and Disposition September 2014, 42 (9) 1411-1422; DOI: https://doi.org/10.1124/dmd.114.057943
    2. The Need for Human Breast Cancer Resistance Protein Substrate and Inhibition Evaluation in Drug Discovery and Development: Why, When, and How?
      Agnès Poirier, Renée Portmann, Anne-Christine Cascais, Urs Bader, Isabelle Walter, Mohammed Ullah and Christoph Funk
      Drug Metabolism and Disposition September 2014, 42 (9) 1466-1477; DOI: https://doi.org/10.1124/dmd.114.058248

G

  1. Galetin, Aleksandra

    1. Hepatic, Intestinal, Renal, and Plasma Hydrolysis of Prodrugs in Human, Cynomolgus Monkey, Dog, and Rat: Implications for In Vitro–In Vivo Extrapolation of Clearance of Prodrugs
      Haruka Nishimuta, J. Brian Houston and Aleksandra Galetin
      Drug Metabolism and Disposition September 2014, 42 (9) 1522-1531; DOI: https://doi.org/10.1124/dmd.114.057372

  2. Gallemann, Dieter

    1. Time- and NADPH-Dependent Inhibition of Cytochrome P450 3A4 by the Cyclopentapeptide Cilengitide: Significance of the Guanidine Group and Accompanying Spectral Changes
      Mirza Bojić, Luca Barbero, Hugues Dolgos, Achim Freisleben, Dieter Gallemann, Simona Riva and F. Peter Guengerich
      Drug Metabolism and Disposition September 2014, 42 (9) 1438-1446; DOI: https://doi.org/10.1124/dmd.114.059295

  3. Greer, Aleksandra K.

    1. A Potential Role for Human UDP-Glucuronosyltransferase 1A4 Promoter Single Nucleotide Polymorphisms in the Pharmacogenomics of Tamoxifen and Its Derivatives
      Aleksandra K. Greer, Centdrika R. Dates, Athena Starlard-Davenport, Vineetha K. Edavana, Stacie M. Bratton, Ishwori B. Dhakal, Moshe Finel, Susan A. Kadlubar and Anna Radominska-Pandya
      Drug Metabolism and Disposition September 2014, 42 (9) 1392-1400; DOI: https://doi.org/10.1124/dmd.114.058016

  4. Guengerich, F. Peter

    1. Time- and NADPH-Dependent Inhibition of Cytochrome P450 3A4 by the Cyclopentapeptide Cilengitide: Significance of the Guanidine Group and Accompanying Spectral Changes
      Mirza Bojić, Luca Barbero, Hugues Dolgos, Achim Freisleben, Dieter Gallemann, Simona Riva and F. Peter Guengerich
      Drug Metabolism and Disposition September 2014, 42 (9) 1438-1446; DOI: https://doi.org/10.1124/dmd.114.059295

  5. Guguen-Guillouzo, Christiane

    1. Impact of Inflammation on Chlorpromazine-Induced Cytotoxicity and Cholestatic Features in HepaRG Cells
      Pamela Bachour-El Azzi, Ahmad Sharanek, Ziad Abdel-Razzak, Sebastien Antherieu, Houssein Al-Attrache, Camille C. Savary, Sylvie Lepage, Isabelle Morel, Gilles Labbe, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition September 2014, 42 (9) 1556-1566; DOI: https://doi.org/10.1124/dmd.114.058123

  6. Guillouzo, André

    1. Impact of Inflammation on Chlorpromazine-Induced Cytotoxicity and Cholestatic Features in HepaRG Cells
      Pamela Bachour-El Azzi, Ahmad Sharanek, Ziad Abdel-Razzak, Sebastien Antherieu, Houssein Al-Attrache, Camille C. Savary, Sylvie Lepage, Isabelle Morel, Gilles Labbe, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition September 2014, 42 (9) 1556-1566; DOI: https://doi.org/10.1124/dmd.114.058123

  7. Gunji, Emi

    1. A Strategy for Assessing Potential Drug-Drug Interactions of a Concomitant Agent against a Drug Absorbed via an Intestinal Transporter in Humans
      Akiko Mizuno-Yasuhira, Yasuhiro Nakai, Emi Gunji, Saeko Uchida, Teisuke Takahashi, Kohnosuke Kinoshita, Shigeji Jingu, Soichi Sakai, Yoshishige Samukawa and Jun-ichi Yamaguchi
      Drug Metabolism and Disposition September 2014, 42 (9) 1456-1465; DOI: https://doi.org/10.1124/dmd.114.058305

H

  1. Hasegawa, Takuro

    1. Interindividual Variations in Metabolism and Pharmacokinetics of 3-(6-Methylpyridine-3-yl-sulfanyl)-6-(4H-[1,2,4]triazole-3-yl-sulfanyl)-N-(1,3-thiazole-2-yl)-2-pyridine carboxamide, a Glucokinase Activator, in Rats Caused by the Genetic Polymorphism of CYP2D1
      Takuro Hasegawa, Jun-ichi Eiki and Masato Chiba
      Drug Metabolism and Disposition September 2014, 42 (9) 1548-1555; DOI: https://doi.org/10.1124/dmd.114.058081

  2. Hauer, Almuthe C.

    1. Inflammatory Bowel Disease Alters Intestinal Bile Acid Transporter Expression
      Jörg Jahnel, Peter Fickert, Almuthe C. Hauer, Christoph Högenauer, Alexander Avian and Michael Trauner
      Drug Metabolism and Disposition September 2014, 42 (9) 1423-1431; DOI: https://doi.org/10.1124/dmd.114.058065

  3. Hillebrecht, Alexander

    1. Calibration of In Vitro Multidrug Resistance Protein 1 Substrate and Inhibition Assays as a Basis to Support the Prediction of Clinically Relevant Interactions In Vivo
      Agnès Poirier, Anne-Christine Cascais, Urs Bader, Renée Portmann, Marie-Elise Brun, Isabelle Walter, Alexander Hillebrecht, Mohammed Ullah and Christoph Funk
      Drug Metabolism and Disposition September 2014, 42 (9) 1411-1422; DOI: https://doi.org/10.1124/dmd.114.057943

  4. Hirota, Takeshi

    1. Identification and Functional Characterization of Novel Nonsynonymous Variants in the Human Multidrug and Toxin Extrusion 2-K
      Kenta Nishimura, Ryosuke Ide, Takeshi Hirota, Kana Kawazu, Sho Kodama, Hiroaki Takesue and Ichiro Ieiri
      Drug Metabolism and Disposition September 2014, 42 (9) 1432-1437; DOI: https://doi.org/10.1124/dmd.114.056887

  5. Ho, Thuy

    1. Evaluation of Calibration Curve–Based Approaches to Predict Clinical Inducers and Noninducers of CYP3A4 with Plated Human Hepatocytes
      J. George Zhang, Thuy Ho, Alanna L. Callendrello, Robert J. Clark, Elizabeth A. Santone, Sarah Kinsman, Deqing Xiao, Lisa G. Fox, Heidi J. Einolf and David M. Stresser
      Drug Metabolism and Disposition September 2014, 42 (9) 1379-1391; DOI: https://doi.org/10.1124/dmd.114.058602

  6. Högenauer, Christoph

    1. Inflammatory Bowel Disease Alters Intestinal Bile Acid Transporter Expression
      Jörg Jahnel, Peter Fickert, Almuthe C. Hauer, Christoph Högenauer, Alexander Avian and Michael Trauner
      Drug Metabolism and Disposition September 2014, 42 (9) 1423-1431; DOI: https://doi.org/10.1124/dmd.114.058065

  7. Holmgren, Gustav

    1. Long-Term Chronic Toxicity Testing Using Human Pluripotent Stem Cell–Derived Hepatocytes
      Gustav Holmgren, Anna-Karin Sjögren, Isabel Barragan, Alan Sabirsh, Peter Sartipy, Jane Synnergren, Petter Björquist, Magnus Ingelman-Sundberg, Tommy B. Andersson and Josefina Edsbagge
      Drug Metabolism and Disposition September 2014, 42 (9) 1401-1406; DOI: https://doi.org/10.1124/dmd.114.059154

  8. Hou, Xiangyu

    1. Dynamic and Coordinated Regulation of KEAP1-NRF2-ARE and p53/p21 Signaling Pathways Is Associated with Acetaminophen Injury Responsive Liver Regeneration
      Xiaomei Fan, Pan Chen, Huasen Tan, Hang Zeng, Yiming Jiang, Ying Wang, Yongtao Wang, Xiangyu Hou, Huichang Bi and Min Huang
      Drug Metabolism and Disposition September 2014, 42 (9) 1532-1539; DOI: https://doi.org/10.1124/dmd.114.059394

  9. Houston, J. Brian

    1. Hepatic, Intestinal, Renal, and Plasma Hydrolysis of Prodrugs in Human, Cynomolgus Monkey, Dog, and Rat: Implications for In Vitro–In Vivo Extrapolation of Clearance of Prodrugs
      Haruka Nishimuta, J. Brian Houston and Aleksandra Galetin
      Drug Metabolism and Disposition September 2014, 42 (9) 1522-1531; DOI: https://doi.org/10.1124/dmd.114.057372

  10. Huang, Min

    1. Dynamic and Coordinated Regulation of KEAP1-NRF2-ARE and p53/p21 Signaling Pathways Is Associated with Acetaminophen Injury Responsive Liver Regeneration
      Xiaomei Fan, Pan Chen, Huasen Tan, Hang Zeng, Yiming Jiang, Ying Wang, Yongtao Wang, Xiangyu Hou, Huichang Bi and Min Huang
      Drug Metabolism and Disposition September 2014, 42 (9) 1532-1539; DOI: https://doi.org/10.1124/dmd.114.059394

  11. Humphries, Helen

    1. Deciding on Success Criteria for Predictability of Pharmacokinetic Parameters from In Vitro Studies: An Analysis Based on In Vivo Observations
      Khaled Abduljalil, Theresa Cain, Helen Humphries and Amin Rostami-Hodjegan
      Drug Metabolism and Disposition September 2014, 42 (9) 1478-1484; DOI: https://doi.org/10.1124/dmd.114.058099

  12. Huwyler, Jörg

    1. Prediction of Organic Anion-Transporting Polypeptide 1B1- and 1B3-Mediated Hepatic Uptake of Statins Based on Transporter Protein Expression and Activity Data
      Annett Kunze, Jörg Huwyler, Gian Camenisch and Birk Poller
      Drug Metabolism and Disposition September 2014, 42 (9) 1514-1521; DOI: https://doi.org/10.1124/dmd.114.058412

I

  1. Ide, Ryosuke

    1. Identification and Functional Characterization of Novel Nonsynonymous Variants in the Human Multidrug and Toxin Extrusion 2-K
      Kenta Nishimura, Ryosuke Ide, Takeshi Hirota, Kana Kawazu, Sho Kodama, Hiroaki Takesue and Ichiro Ieiri
      Drug Metabolism and Disposition September 2014, 42 (9) 1432-1437; DOI: https://doi.org/10.1124/dmd.114.056887

  2. Ieiri, Ichiro

    1. Identification and Functional Characterization of Novel Nonsynonymous Variants in the Human Multidrug and Toxin Extrusion 2-K
      Kenta Nishimura, Ryosuke Ide, Takeshi Hirota, Kana Kawazu, Sho Kodama, Hiroaki Takesue and Ichiro Ieiri
      Drug Metabolism and Disposition September 2014, 42 (9) 1432-1437; DOI: https://doi.org/10.1124/dmd.114.056887

  3. Ingelman-Sundberg, Magnus

    1. Long-Term Chronic Toxicity Testing Using Human Pluripotent Stem Cell–Derived Hepatocytes
      Gustav Holmgren, Anna-Karin Sjögren, Isabel Barragan, Alan Sabirsh, Peter Sartipy, Jane Synnergren, Petter Björquist, Magnus Ingelman-Sundberg, Tommy B. Andersson and Josefina Edsbagge
      Drug Metabolism and Disposition September 2014, 42 (9) 1401-1406; DOI: https://doi.org/10.1124/dmd.114.059154

  4. Ishigai, Masaki

    1. A Useful Model Capable of Predicting the Clearance of Cytochrome P450 3A4 (CYP3A4) Substrates in Humans: Validity of CYP3A4 Transgenic Mice Lacking Their Own Cyp3a Enzymes
      Tetsuya Mitsui, Takayuki Nemoto, Taiji Miyake, Shunsuke Nagao, Kotaro Ogawa, Motohiro Kato, Masaki Ishigai and Hideyuki Yamada
      Drug Metabolism and Disposition September 2014, 42 (9) 1540-1547; DOI: https://doi.org/10.1124/dmd.114.057935

  5. Ishii, Yuji

    1. Effect of CYP2A6 Genetic Polymorphism on the Metabolic Conversion of Tegafur to 5-Fluorouracil and Its Enantioselectivity
      Ikuo Yamamiya, Kunihiro Yoshisue, Yuji Ishii, Hideyuki Yamada and Masato Chiba
      Drug Metabolism and Disposition September 2014, 42 (9) 1485-1492; DOI: https://doi.org/10.1124/dmd.114.058008

J

  1. Jahnel, Jörg

    1. Inflammatory Bowel Disease Alters Intestinal Bile Acid Transporter Expression
      Jörg Jahnel, Peter Fickert, Almuthe C. Hauer, Christoph Högenauer, Alexander Avian and Michael Trauner
      Drug Metabolism and Disposition September 2014, 42 (9) 1423-1431; DOI: https://doi.org/10.1124/dmd.114.058065

  2. Jiang, Yiming

    1. Dynamic and Coordinated Regulation of KEAP1-NRF2-ARE and p53/p21 Signaling Pathways Is Associated with Acetaminophen Injury Responsive Liver Regeneration
      Xiaomei Fan, Pan Chen, Huasen Tan, Hang Zeng, Yiming Jiang, Ying Wang, Yongtao Wang, Xiangyu Hou, Huichang Bi and Min Huang
      Drug Metabolism and Disposition September 2014, 42 (9) 1532-1539; DOI: https://doi.org/10.1124/dmd.114.059394

  3. Jingu, Shigeji

    1. A Strategy for Assessing Potential Drug-Drug Interactions of a Concomitant Agent against a Drug Absorbed via an Intestinal Transporter in Humans
      Akiko Mizuno-Yasuhira, Yasuhiro Nakai, Emi Gunji, Saeko Uchida, Teisuke Takahashi, Kohnosuke Kinoshita, Shigeji Jingu, Soichi Sakai, Yoshishige Samukawa and Jun-ichi Yamaguchi
      Drug Metabolism and Disposition September 2014, 42 (9) 1456-1465; DOI: https://doi.org/10.1124/dmd.114.058305

  4. Jones, Jeffrey P.

    1. A Numerical Method for Analysis of In Vitro Time-Dependent Inhibition Data. Part 1. Theoretical Considerations
      Swati Nagar, Jeffrey P. Jones and Ken Korzekwa
      Drug Metabolism and Disposition September 2014, 42 (9) 1575-1586; DOI: https://doi.org/10.1124/dmd.114.058289

  5. Jung, Hyun-Jin

    1. Regioselective Hydroxylation of Omeprazole Enantiomers by Bacterial CYP102A1 Mutants
      Sang Hoon Ryu, Bo-Yeon Park, So-Young Kim, Sun-Ha Park, Hyun-Jin Jung, Min Park, Ki Deok Park, Taeho Ahn, Hyung-Sik Kang and Chul-Ho Yun
      Drug Metabolism and Disposition September 2014, 42 (9) 1493-1497; DOI: https://doi.org/10.1124/dmd.114.058636

  6. Jung, Il-Hoon

    1. Gut Microbiota-Mediated Drug Interactions between Lovastatin and Antibiotics
      Dae-Hyoung Yoo, In Sook Kim, Thi Kim Van Le, Il-Hoon Jung, Hye Hyun Yoo and Dong-Hyun Kim
      Drug Metabolism and Disposition September 2014, 42 (9) 1508-1513; DOI: https://doi.org/10.1124/dmd.114.058354

K

  1. Kadlubar, Susan A.

    1. A Potential Role for Human UDP-Glucuronosyltransferase 1A4 Promoter Single Nucleotide Polymorphisms in the Pharmacogenomics of Tamoxifen and Its Derivatives
      Aleksandra K. Greer, Centdrika R. Dates, Athena Starlard-Davenport, Vineetha K. Edavana, Stacie M. Bratton, Ishwori B. Dhakal, Moshe Finel, Susan A. Kadlubar and Anna Radominska-Pandya
      Drug Metabolism and Disposition September 2014, 42 (9) 1392-1400; DOI: https://doi.org/10.1124/dmd.114.058016

  2. Kang, Hyung-Sik

    1. Regioselective Hydroxylation of Omeprazole Enantiomers by Bacterial CYP102A1 Mutants
      Sang Hoon Ryu, Bo-Yeon Park, So-Young Kim, Sun-Ha Park, Hyun-Jin Jung, Min Park, Ki Deok Park, Taeho Ahn, Hyung-Sik Kang and Chul-Ho Yun
      Drug Metabolism and Disposition September 2014, 42 (9) 1493-1497; DOI: https://doi.org/10.1124/dmd.114.058636

  3. Kato, Motohiro

    1. A Useful Model Capable of Predicting the Clearance of Cytochrome P450 3A4 (CYP3A4) Substrates in Humans: Validity of CYP3A4 Transgenic Mice Lacking Their Own Cyp3a Enzymes
      Tetsuya Mitsui, Takayuki Nemoto, Taiji Miyake, Shunsuke Nagao, Kotaro Ogawa, Motohiro Kato, Masaki Ishigai and Hideyuki Yamada
      Drug Metabolism and Disposition September 2014, 42 (9) 1540-1547; DOI: https://doi.org/10.1124/dmd.114.057935

  4. Kawazu, Kana

    1. Identification and Functional Characterization of Novel Nonsynonymous Variants in the Human Multidrug and Toxin Extrusion 2-K
      Kenta Nishimura, Ryosuke Ide, Takeshi Hirota, Kana Kawazu, Sho Kodama, Hiroaki Takesue and Ichiro Ieiri
      Drug Metabolism and Disposition September 2014, 42 (9) 1432-1437; DOI: https://doi.org/10.1124/dmd.114.056887

  5. Kim, Dong-Hyun

    1. Gut Microbiota-Mediated Drug Interactions between Lovastatin and Antibiotics
      Dae-Hyoung Yoo, In Sook Kim, Thi Kim Van Le, Il-Hoon Jung, Hye Hyun Yoo and Dong-Hyun Kim
      Drug Metabolism and Disposition September 2014, 42 (9) 1508-1513; DOI: https://doi.org/10.1124/dmd.114.058354

  6. Kim, In Sook

    1. Gut Microbiota-Mediated Drug Interactions between Lovastatin and Antibiotics
      Dae-Hyoung Yoo, In Sook Kim, Thi Kim Van Le, Il-Hoon Jung, Hye Hyun Yoo and Dong-Hyun Kim
      Drug Metabolism and Disposition September 2014, 42 (9) 1508-1513; DOI: https://doi.org/10.1124/dmd.114.058354

  7. Kim, So-Young

    1. Regioselective Hydroxylation of Omeprazole Enantiomers by Bacterial CYP102A1 Mutants
      Sang Hoon Ryu, Bo-Yeon Park, So-Young Kim, Sun-Ha Park, Hyun-Jin Jung, Min Park, Ki Deok Park, Taeho Ahn, Hyung-Sik Kang and Chul-Ho Yun
      Drug Metabolism and Disposition September 2014, 42 (9) 1493-1497; DOI: https://doi.org/10.1124/dmd.114.058636

  8. Kinoshita, Kohnosuke

    1. A Strategy for Assessing Potential Drug-Drug Interactions of a Concomitant Agent against a Drug Absorbed via an Intestinal Transporter in Humans
      Akiko Mizuno-Yasuhira, Yasuhiro Nakai, Emi Gunji, Saeko Uchida, Teisuke Takahashi, Kohnosuke Kinoshita, Shigeji Jingu, Soichi Sakai, Yoshishige Samukawa and Jun-ichi Yamaguchi
      Drug Metabolism and Disposition September 2014, 42 (9) 1456-1465; DOI: https://doi.org/10.1124/dmd.114.058305

  9. Kinsman, Sarah

    1. Evaluation of Calibration Curve–Based Approaches to Predict Clinical Inducers and Noninducers of CYP3A4 with Plated Human Hepatocytes
      J. George Zhang, Thuy Ho, Alanna L. Callendrello, Robert J. Clark, Elizabeth A. Santone, Sarah Kinsman, Deqing Xiao, Lisa G. Fox, Heidi J. Einolf and David M. Stresser
      Drug Metabolism and Disposition September 2014, 42 (9) 1379-1391; DOI: https://doi.org/10.1124/dmd.114.058602

  10. Köck, Kathleen

    1. Role of Multidrug Resistance–Associated Protein 4 in the Basolateral Efflux of Hepatically Derived Enalaprilat
      Brian C. Ferslew, Kathleen Köck, Arlene S. Bridges and Kim L. R. Brouwer
      Drug Metabolism and Disposition September 2014, 42 (9) 1567-1574; DOI: https://doi.org/10.1124/dmd.114.057554

  11. Kodama, Sho

    1. Identification and Functional Characterization of Novel Nonsynonymous Variants in the Human Multidrug and Toxin Extrusion 2-K
      Kenta Nishimura, Ryosuke Ide, Takeshi Hirota, Kana Kawazu, Sho Kodama, Hiroaki Takesue and Ichiro Ieiri
      Drug Metabolism and Disposition September 2014, 42 (9) 1432-1437; DOI: https://doi.org/10.1124/dmd.114.056887

  12. Kohara, Sakae

    1. Polymorphisms of CYP2D17 in Cynomolgus and Rhesus Macaques: an Evidence of the Genetic Basis for the Variability of CYP2D-Dependent Drug Metabolism
      Yasuhiro Uno, Shotaro Uehara, Sakae Kohara, Norie Murayama and Hiroshi Yamazaki
      Drug Metabolism and Disposition September 2014, 42 (9) 1407-1410; DOI: https://doi.org/10.1124/dmd.114.059220

  13. Korzekwa, Ken

    1. A Numerical Method for Analysis of In Vitro Time-Dependent Inhibition Data. Part 1. Theoretical Considerations
      Swati Nagar, Jeffrey P. Jones and Ken Korzekwa
      Drug Metabolism and Disposition September 2014, 42 (9) 1575-1586; DOI: https://doi.org/10.1124/dmd.114.058289
    2. A Numerical Method for Analysis of In Vitro Time-Dependent Inhibition Data. Part 2. Application to Experimental Data
      Ken Korzekwa, Donald Tweedie, Upendra A. Argikar, Andrea Whitcher-Johnstone, Leslie Bell, Shari Bickford and Swati Nagar
      Drug Metabolism and Disposition September 2014, 42 (9) 1587-1595; DOI: https://doi.org/10.1124/dmd.114.058297

  14. Kunze, Annett

    1. Prediction of Organic Anion-Transporting Polypeptide 1B1- and 1B3-Mediated Hepatic Uptake of Statins Based on Transporter Protein Expression and Activity Data
      Annett Kunze, Jörg Huwyler, Gian Camenisch and Birk Poller
      Drug Metabolism and Disposition September 2014, 42 (9) 1514-1521; DOI: https://doi.org/10.1124/dmd.114.058412

L

  1. Labbe, Gilles

    1. Impact of Inflammation on Chlorpromazine-Induced Cytotoxicity and Cholestatic Features in HepaRG Cells
      Pamela Bachour-El Azzi, Ahmad Sharanek, Ziad Abdel-Razzak, Sebastien Antherieu, Houssein Al-Attrache, Camille C. Savary, Sylvie Lepage, Isabelle Morel, Gilles Labbe, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition September 2014, 42 (9) 1556-1566; DOI: https://doi.org/10.1124/dmd.114.058123

  2. Lepage, Sylvie

    1. Impact of Inflammation on Chlorpromazine-Induced Cytotoxicity and Cholestatic Features in HepaRG Cells
      Pamela Bachour-El Azzi, Ahmad Sharanek, Ziad Abdel-Razzak, Sebastien Antherieu, Houssein Al-Attrache, Camille C. Savary, Sylvie Lepage, Isabelle Morel, Gilles Labbe, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition September 2014, 42 (9) 1556-1566; DOI: https://doi.org/10.1124/dmd.114.058123

  3. Luttringer, Olivier

    1. Translational Pharmacokinetic Modeling of Fingolimod (FTY720) as a Paradigm Compound Subject to Sphingosine Kinase-Mediated Phosphorylation
      Nelleke Snelder, Bart A. Ploeger, Olivier Luttringer, Donald. R. Stanski and Meindert Danhof
      Drug Metabolism and Disposition September 2014, 42 (9) 1367-1378; DOI: https://doi.org/10.1124/dmd.113.056770

M

  1. Miksys, Sharon

    1. Nicotine Pharmacokinetics in Rats Is Altered as a Function of Age, Impacting the Interpretation of Animal Model Data
      Evelyn L. Craig, Bin Zhao, Jason Z. Cui, Maria Novalen, Sharon Miksys and Rachel F. Tyndale
      Drug Metabolism and Disposition September 2014, 42 (9) 1447-1455; DOI: https://doi.org/10.1124/dmd.114.058719

  2. Mitsui, Tetsuya

    1. A Useful Model Capable of Predicting the Clearance of Cytochrome P450 3A4 (CYP3A4) Substrates in Humans: Validity of CYP3A4 Transgenic Mice Lacking Their Own Cyp3a Enzymes
      Tetsuya Mitsui, Takayuki Nemoto, Taiji Miyake, Shunsuke Nagao, Kotaro Ogawa, Motohiro Kato, Masaki Ishigai and Hideyuki Yamada
      Drug Metabolism and Disposition September 2014, 42 (9) 1540-1547; DOI: https://doi.org/10.1124/dmd.114.057935

  3. Miyake, Taiji

    1. A Useful Model Capable of Predicting the Clearance of Cytochrome P450 3A4 (CYP3A4) Substrates in Humans: Validity of CYP3A4 Transgenic Mice Lacking Their Own Cyp3a Enzymes
      Tetsuya Mitsui, Takayuki Nemoto, Taiji Miyake, Shunsuke Nagao, Kotaro Ogawa, Motohiro Kato, Masaki Ishigai and Hideyuki Yamada
      Drug Metabolism and Disposition September 2014, 42 (9) 1540-1547; DOI: https://doi.org/10.1124/dmd.114.057935

  4. Mizuno-Yasuhira, Akiko

    1. A Strategy for Assessing Potential Drug-Drug Interactions of a Concomitant Agent against a Drug Absorbed via an Intestinal Transporter in Humans
      Akiko Mizuno-Yasuhira, Yasuhiro Nakai, Emi Gunji, Saeko Uchida, Teisuke Takahashi, Kohnosuke Kinoshita, Shigeji Jingu, Soichi Sakai, Yoshishige Samukawa and Jun-ichi Yamaguchi
      Drug Metabolism and Disposition September 2014, 42 (9) 1456-1465; DOI: https://doi.org/10.1124/dmd.114.058305

  5. Morel, Isabelle

    1. Impact of Inflammation on Chlorpromazine-Induced Cytotoxicity and Cholestatic Features in HepaRG Cells
      Pamela Bachour-El Azzi, Ahmad Sharanek, Ziad Abdel-Razzak, Sebastien Antherieu, Houssein Al-Attrache, Camille C. Savary, Sylvie Lepage, Isabelle Morel, Gilles Labbe, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition September 2014, 42 (9) 1556-1566; DOI: https://doi.org/10.1124/dmd.114.058123

  6. Morris, Marilyn E.

    1. Flavonoids Are Inhibitors of Human Organic Anion Transporter 1 (OAT1)–Mediated Transport
      Guohua An, Xiaodong Wang and Marilyn E. Morris
      Drug Metabolism and Disposition September 2014, 42 (9) 1357-1366; DOI: https://doi.org/10.1124/dmd.114.059337

  7. Murayama, Norie

    1. Polymorphisms of CYP2D17 in Cynomolgus and Rhesus Macaques: an Evidence of the Genetic Basis for the Variability of CYP2D-Dependent Drug Metabolism
      Yasuhiro Uno, Shotaro Uehara, Sakae Kohara, Norie Murayama and Hiroshi Yamazaki
      Drug Metabolism and Disposition September 2014, 42 (9) 1407-1410; DOI: https://doi.org/10.1124/dmd.114.059220

N

  1. Nagao, Shunsuke

    1. A Useful Model Capable of Predicting the Clearance of Cytochrome P450 3A4 (CYP3A4) Substrates in Humans: Validity of CYP3A4 Transgenic Mice Lacking Their Own Cyp3a Enzymes
      Tetsuya Mitsui, Takayuki Nemoto, Taiji Miyake, Shunsuke Nagao, Kotaro Ogawa, Motohiro Kato, Masaki Ishigai and Hideyuki Yamada
      Drug Metabolism and Disposition September 2014, 42 (9) 1540-1547; DOI: https://doi.org/10.1124/dmd.114.057935

  2. Nagar, Swati

    1. A Numerical Method for Analysis of In Vitro Time-Dependent Inhibition Data. Part 1. Theoretical Considerations
      Swati Nagar, Jeffrey P. Jones and Ken Korzekwa
      Drug Metabolism and Disposition September 2014, 42 (9) 1575-1586; DOI: https://doi.org/10.1124/dmd.114.058289
    2. A Numerical Method for Analysis of In Vitro Time-Dependent Inhibition Data. Part 2. Application to Experimental Data
      Ken Korzekwa, Donald Tweedie, Upendra A. Argikar, Andrea Whitcher-Johnstone, Leslie Bell, Shari Bickford and Swati Nagar
      Drug Metabolism and Disposition September 2014, 42 (9) 1587-1595; DOI: https://doi.org/10.1124/dmd.114.058297

  3. Nakai, Yasuhiro

    1. A Strategy for Assessing Potential Drug-Drug Interactions of a Concomitant Agent against a Drug Absorbed via an Intestinal Transporter in Humans
      Akiko Mizuno-Yasuhira, Yasuhiro Nakai, Emi Gunji, Saeko Uchida, Teisuke Takahashi, Kohnosuke Kinoshita, Shigeji Jingu, Soichi Sakai, Yoshishige Samukawa and Jun-ichi Yamaguchi
      Drug Metabolism and Disposition September 2014, 42 (9) 1456-1465; DOI: https://doi.org/10.1124/dmd.114.058305

  4. Nemoto, Takayuki

    1. A Useful Model Capable of Predicting the Clearance of Cytochrome P450 3A4 (CYP3A4) Substrates in Humans: Validity of CYP3A4 Transgenic Mice Lacking Their Own Cyp3a Enzymes
      Tetsuya Mitsui, Takayuki Nemoto, Taiji Miyake, Shunsuke Nagao, Kotaro Ogawa, Motohiro Kato, Masaki Ishigai and Hideyuki Yamada
      Drug Metabolism and Disposition September 2014, 42 (9) 1540-1547; DOI: https://doi.org/10.1124/dmd.114.057935

  5. Nishimura, Kenta

    1. Identification and Functional Characterization of Novel Nonsynonymous Variants in the Human Multidrug and Toxin Extrusion 2-K
      Kenta Nishimura, Ryosuke Ide, Takeshi Hirota, Kana Kawazu, Sho Kodama, Hiroaki Takesue and Ichiro Ieiri
      Drug Metabolism and Disposition September 2014, 42 (9) 1432-1437; DOI: https://doi.org/10.1124/dmd.114.056887

  6. Nishimuta, Haruka

    1. Hepatic, Intestinal, Renal, and Plasma Hydrolysis of Prodrugs in Human, Cynomolgus Monkey, Dog, and Rat: Implications for In Vitro–In Vivo Extrapolation of Clearance of Prodrugs
      Haruka Nishimuta, J. Brian Houston and Aleksandra Galetin
      Drug Metabolism and Disposition September 2014, 42 (9) 1522-1531; DOI: https://doi.org/10.1124/dmd.114.057372

  7. Novalen, Maria

    1. Nicotine Pharmacokinetics in Rats Is Altered as a Function of Age, Impacting the Interpretation of Animal Model Data
      Evelyn L. Craig, Bin Zhao, Jason Z. Cui, Maria Novalen, Sharon Miksys and Rachel F. Tyndale
      Drug Metabolism and Disposition September 2014, 42 (9) 1447-1455; DOI: https://doi.org/10.1124/dmd.114.058719

O

  1. Ogawa, Kotaro

    1. A Useful Model Capable of Predicting the Clearance of Cytochrome P450 3A4 (CYP3A4) Substrates in Humans: Validity of CYP3A4 Transgenic Mice Lacking Their Own Cyp3a Enzymes
      Tetsuya Mitsui, Takayuki Nemoto, Taiji Miyake, Shunsuke Nagao, Kotaro Ogawa, Motohiro Kato, Masaki Ishigai and Hideyuki Yamada
      Drug Metabolism and Disposition September 2014, 42 (9) 1540-1547; DOI: https://doi.org/10.1124/dmd.114.057935

P

  1. Park, Bo-Yeon

    1. Regioselective Hydroxylation of Omeprazole Enantiomers by Bacterial CYP102A1 Mutants
      Sang Hoon Ryu, Bo-Yeon Park, So-Young Kim, Sun-Ha Park, Hyun-Jin Jung, Min Park, Ki Deok Park, Taeho Ahn, Hyung-Sik Kang and Chul-Ho Yun
      Drug Metabolism and Disposition September 2014, 42 (9) 1493-1497; DOI: https://doi.org/10.1124/dmd.114.058636

  2. Park, Ki Deok

    1. Regioselective Hydroxylation of Omeprazole Enantiomers by Bacterial CYP102A1 Mutants
      Sang Hoon Ryu, Bo-Yeon Park, So-Young Kim, Sun-Ha Park, Hyun-Jin Jung, Min Park, Ki Deok Park, Taeho Ahn, Hyung-Sik Kang and Chul-Ho Yun
      Drug Metabolism and Disposition September 2014, 42 (9) 1493-1497; DOI: https://doi.org/10.1124/dmd.114.058636

  3. Park, Min

    1. Regioselective Hydroxylation of Omeprazole Enantiomers by Bacterial CYP102A1 Mutants
      Sang Hoon Ryu, Bo-Yeon Park, So-Young Kim, Sun-Ha Park, Hyun-Jin Jung, Min Park, Ki Deok Park, Taeho Ahn, Hyung-Sik Kang and Chul-Ho Yun
      Drug Metabolism and Disposition September 2014, 42 (9) 1493-1497; DOI: https://doi.org/10.1124/dmd.114.058636

  4. Park, Sun-Ha

    1. Regioselective Hydroxylation of Omeprazole Enantiomers by Bacterial CYP102A1 Mutants
      Sang Hoon Ryu, Bo-Yeon Park, So-Young Kim, Sun-Ha Park, Hyun-Jin Jung, Min Park, Ki Deok Park, Taeho Ahn, Hyung-Sik Kang and Chul-Ho Yun
      Drug Metabolism and Disposition September 2014, 42 (9) 1493-1497; DOI: https://doi.org/10.1124/dmd.114.058636

  5. Ploeger, Bart A.

    1. Translational Pharmacokinetic Modeling of Fingolimod (FTY720) as a Paradigm Compound Subject to Sphingosine Kinase-Mediated Phosphorylation
      Nelleke Snelder, Bart A. Ploeger, Olivier Luttringer, Donald. R. Stanski and Meindert Danhof
      Drug Metabolism and Disposition September 2014, 42 (9) 1367-1378; DOI: https://doi.org/10.1124/dmd.113.056770

  6. Poirier, Agnès

    1. Calibration of In Vitro Multidrug Resistance Protein 1 Substrate and Inhibition Assays as a Basis to Support the Prediction of Clinically Relevant Interactions In Vivo
      Agnès Poirier, Anne-Christine Cascais, Urs Bader, Renée Portmann, Marie-Elise Brun, Isabelle Walter, Alexander Hillebrecht, Mohammed Ullah and Christoph Funk
      Drug Metabolism and Disposition September 2014, 42 (9) 1411-1422; DOI: https://doi.org/10.1124/dmd.114.057943
    2. The Need for Human Breast Cancer Resistance Protein Substrate and Inhibition Evaluation in Drug Discovery and Development: Why, When, and How?
      Agnès Poirier, Renée Portmann, Anne-Christine Cascais, Urs Bader, Isabelle Walter, Mohammed Ullah and Christoph Funk
      Drug Metabolism and Disposition September 2014, 42 (9) 1466-1477; DOI: https://doi.org/10.1124/dmd.114.058248

  7. Poller, Birk

    1. Prediction of Organic Anion-Transporting Polypeptide 1B1- and 1B3-Mediated Hepatic Uptake of Statins Based on Transporter Protein Expression and Activity Data
      Annett Kunze, Jörg Huwyler, Gian Camenisch and Birk Poller
      Drug Metabolism and Disposition September 2014, 42 (9) 1514-1521; DOI: https://doi.org/10.1124/dmd.114.058412

  8. Portmann, Renée

    1. Calibration of In Vitro Multidrug Resistance Protein 1 Substrate and Inhibition Assays as a Basis to Support the Prediction of Clinically Relevant Interactions In Vivo
      Agnès Poirier, Anne-Christine Cascais, Urs Bader, Renée Portmann, Marie-Elise Brun, Isabelle Walter, Alexander Hillebrecht, Mohammed Ullah and Christoph Funk
      Drug Metabolism and Disposition September 2014, 42 (9) 1411-1422; DOI: https://doi.org/10.1124/dmd.114.057943
    2. The Need for Human Breast Cancer Resistance Protein Substrate and Inhibition Evaluation in Drug Discovery and Development: Why, When, and How?
      Agnès Poirier, Renée Portmann, Anne-Christine Cascais, Urs Bader, Isabelle Walter, Mohammed Ullah and Christoph Funk
      Drug Metabolism and Disposition September 2014, 42 (9) 1466-1477; DOI: https://doi.org/10.1124/dmd.114.058248

R

  1. Radominska-Pandya, Anna

    1. A Potential Role for Human UDP-Glucuronosyltransferase 1A4 Promoter Single Nucleotide Polymorphisms in the Pharmacogenomics of Tamoxifen and Its Derivatives
      Aleksandra K. Greer, Centdrika R. Dates, Athena Starlard-Davenport, Vineetha K. Edavana, Stacie M. Bratton, Ishwori B. Dhakal, Moshe Finel, Susan A. Kadlubar and Anna Radominska-Pandya
      Drug Metabolism and Disposition September 2014, 42 (9) 1392-1400; DOI: https://doi.org/10.1124/dmd.114.058016

  2. Riva, Simona

    1. Time- and NADPH-Dependent Inhibition of Cytochrome P450 3A4 by the Cyclopentapeptide Cilengitide: Significance of the Guanidine Group and Accompanying Spectral Changes
      Mirza Bojić, Luca Barbero, Hugues Dolgos, Achim Freisleben, Dieter Gallemann, Simona Riva and F. Peter Guengerich
      Drug Metabolism and Disposition September 2014, 42 (9) 1438-1446; DOI: https://doi.org/10.1124/dmd.114.059295

  3. Rostami-Hodjegan, Amin

    1. Deciding on Success Criteria for Predictability of Pharmacokinetic Parameters from In Vitro Studies: An Analysis Based on In Vivo Observations
      Khaled Abduljalil, Theresa Cain, Helen Humphries and Amin Rostami-Hodjegan
      Drug Metabolism and Disposition September 2014, 42 (9) 1478-1484; DOI: https://doi.org/10.1124/dmd.114.058099

  4. Ryu, Sang Hoon

    1. Regioselective Hydroxylation of Omeprazole Enantiomers by Bacterial CYP102A1 Mutants
      Sang Hoon Ryu, Bo-Yeon Park, So-Young Kim, Sun-Ha Park, Hyun-Jin Jung, Min Park, Ki Deok Park, Taeho Ahn, Hyung-Sik Kang and Chul-Ho Yun
      Drug Metabolism and Disposition September 2014, 42 (9) 1493-1497; DOI: https://doi.org/10.1124/dmd.114.058636

S

  1. Sabirsh, Alan

    1. Long-Term Chronic Toxicity Testing Using Human Pluripotent Stem Cell–Derived Hepatocytes
      Gustav Holmgren, Anna-Karin Sjögren, Isabel Barragan, Alan Sabirsh, Peter Sartipy, Jane Synnergren, Petter Björquist, Magnus Ingelman-Sundberg, Tommy B. Andersson and Josefina Edsbagge
      Drug Metabolism and Disposition September 2014, 42 (9) 1401-1406; DOI: https://doi.org/10.1124/dmd.114.059154

  2. Sakai, Soichi

    1. A Strategy for Assessing Potential Drug-Drug Interactions of a Concomitant Agent against a Drug Absorbed via an Intestinal Transporter in Humans
      Akiko Mizuno-Yasuhira, Yasuhiro Nakai, Emi Gunji, Saeko Uchida, Teisuke Takahashi, Kohnosuke Kinoshita, Shigeji Jingu, Soichi Sakai, Yoshishige Samukawa and Jun-ichi Yamaguchi
      Drug Metabolism and Disposition September 2014, 42 (9) 1456-1465; DOI: https://doi.org/10.1124/dmd.114.058305

  3. Samukawa, Yoshishige

    1. A Strategy for Assessing Potential Drug-Drug Interactions of a Concomitant Agent against a Drug Absorbed via an Intestinal Transporter in Humans
      Akiko Mizuno-Yasuhira, Yasuhiro Nakai, Emi Gunji, Saeko Uchida, Teisuke Takahashi, Kohnosuke Kinoshita, Shigeji Jingu, Soichi Sakai, Yoshishige Samukawa and Jun-ichi Yamaguchi
      Drug Metabolism and Disposition September 2014, 42 (9) 1456-1465; DOI: https://doi.org/10.1124/dmd.114.058305

  4. Santone, Elizabeth A.

    1. Evaluation of Calibration Curve–Based Approaches to Predict Clinical Inducers and Noninducers of CYP3A4 with Plated Human Hepatocytes
      J. George Zhang, Thuy Ho, Alanna L. Callendrello, Robert J. Clark, Elizabeth A. Santone, Sarah Kinsman, Deqing Xiao, Lisa G. Fox, Heidi J. Einolf and David M. Stresser
      Drug Metabolism and Disposition September 2014, 42 (9) 1379-1391; DOI: https://doi.org/10.1124/dmd.114.058602

  5. Sartipy, Peter

    1. Long-Term Chronic Toxicity Testing Using Human Pluripotent Stem Cell–Derived Hepatocytes
      Gustav Holmgren, Anna-Karin Sjögren, Isabel Barragan, Alan Sabirsh, Peter Sartipy, Jane Synnergren, Petter Björquist, Magnus Ingelman-Sundberg, Tommy B. Andersson and Josefina Edsbagge
      Drug Metabolism and Disposition September 2014, 42 (9) 1401-1406; DOI: https://doi.org/10.1124/dmd.114.059154

  6. Savary, Camille C.

    1. Impact of Inflammation on Chlorpromazine-Induced Cytotoxicity and Cholestatic Features in HepaRG Cells
      Pamela Bachour-El Azzi, Ahmad Sharanek, Ziad Abdel-Razzak, Sebastien Antherieu, Houssein Al-Attrache, Camille C. Savary, Sylvie Lepage, Isabelle Morel, Gilles Labbe, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition September 2014, 42 (9) 1556-1566; DOI: https://doi.org/10.1124/dmd.114.058123

  7. Sharanek, Ahmad

    1. Impact of Inflammation on Chlorpromazine-Induced Cytotoxicity and Cholestatic Features in HepaRG Cells
      Pamela Bachour-El Azzi, Ahmad Sharanek, Ziad Abdel-Razzak, Sebastien Antherieu, Houssein Al-Attrache, Camille C. Savary, Sylvie Lepage, Isabelle Morel, Gilles Labbe, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition September 2014, 42 (9) 1556-1566; DOI: https://doi.org/10.1124/dmd.114.058123

  8. Sjögren, Anna-Karin

    1. Long-Term Chronic Toxicity Testing Using Human Pluripotent Stem Cell–Derived Hepatocytes
      Gustav Holmgren, Anna-Karin Sjögren, Isabel Barragan, Alan Sabirsh, Peter Sartipy, Jane Synnergren, Petter Björquist, Magnus Ingelman-Sundberg, Tommy B. Andersson and Josefina Edsbagge
      Drug Metabolism and Disposition September 2014, 42 (9) 1401-1406; DOI: https://doi.org/10.1124/dmd.114.059154

  9. Snelder, Nelleke

    1. Translational Pharmacokinetic Modeling of Fingolimod (FTY720) as a Paradigm Compound Subject to Sphingosine Kinase-Mediated Phosphorylation
      Nelleke Snelder, Bart A. Ploeger, Olivier Luttringer, Donald. R. Stanski and Meindert Danhof
      Drug Metabolism and Disposition September 2014, 42 (9) 1367-1378; DOI: https://doi.org/10.1124/dmd.113.056770

  10. Stanski, Donald. R.

    1. Translational Pharmacokinetic Modeling of Fingolimod (FTY720) as a Paradigm Compound Subject to Sphingosine Kinase-Mediated Phosphorylation
      Nelleke Snelder, Bart A. Ploeger, Olivier Luttringer, Donald. R. Stanski and Meindert Danhof
      Drug Metabolism and Disposition September 2014, 42 (9) 1367-1378; DOI: https://doi.org/10.1124/dmd.113.056770

  11. Starlard-Davenport, Athena

    1. A Potential Role for Human UDP-Glucuronosyltransferase 1A4 Promoter Single Nucleotide Polymorphisms in the Pharmacogenomics of Tamoxifen and Its Derivatives
      Aleksandra K. Greer, Centdrika R. Dates, Athena Starlard-Davenport, Vineetha K. Edavana, Stacie M. Bratton, Ishwori B. Dhakal, Moshe Finel, Susan A. Kadlubar and Anna Radominska-Pandya
      Drug Metabolism and Disposition September 2014, 42 (9) 1392-1400; DOI: https://doi.org/10.1124/dmd.114.058016

  12. Stresser, David M.

    1. Evaluation of Calibration Curve–Based Approaches to Predict Clinical Inducers and Noninducers of CYP3A4 with Plated Human Hepatocytes
      J. George Zhang, Thuy Ho, Alanna L. Callendrello, Robert J. Clark, Elizabeth A. Santone, Sarah Kinsman, Deqing Xiao, Lisa G. Fox, Heidi J. Einolf and David M. Stresser
      Drug Metabolism and Disposition September 2014, 42 (9) 1379-1391; DOI: https://doi.org/10.1124/dmd.114.058602

  13. Synnergren, Jane

    1. Long-Term Chronic Toxicity Testing Using Human Pluripotent Stem Cell–Derived Hepatocytes
      Gustav Holmgren, Anna-Karin Sjögren, Isabel Barragan, Alan Sabirsh, Peter Sartipy, Jane Synnergren, Petter Björquist, Magnus Ingelman-Sundberg, Tommy B. Andersson and Josefina Edsbagge
      Drug Metabolism and Disposition September 2014, 42 (9) 1401-1406; DOI: https://doi.org/10.1124/dmd.114.059154

T

  1. Takahashi, Teisuke

    1. A Strategy for Assessing Potential Drug-Drug Interactions of a Concomitant Agent against a Drug Absorbed via an Intestinal Transporter in Humans
      Akiko Mizuno-Yasuhira, Yasuhiro Nakai, Emi Gunji, Saeko Uchida, Teisuke Takahashi, Kohnosuke Kinoshita, Shigeji Jingu, Soichi Sakai, Yoshishige Samukawa and Jun-ichi Yamaguchi
      Drug Metabolism and Disposition September 2014, 42 (9) 1456-1465; DOI: https://doi.org/10.1124/dmd.114.058305

  2. Takesue, Hiroaki

    1. Identification and Functional Characterization of Novel Nonsynonymous Variants in the Human Multidrug and Toxin Extrusion 2-K
      Kenta Nishimura, Ryosuke Ide, Takeshi Hirota, Kana Kawazu, Sho Kodama, Hiroaki Takesue and Ichiro Ieiri
      Drug Metabolism and Disposition September 2014, 42 (9) 1432-1437; DOI: https://doi.org/10.1124/dmd.114.056887

  3. Tan, Huasen

    1. Dynamic and Coordinated Regulation of KEAP1-NRF2-ARE and p53/p21 Signaling Pathways Is Associated with Acetaminophen Injury Responsive Liver Regeneration
      Xiaomei Fan, Pan Chen, Huasen Tan, Hang Zeng, Yiming Jiang, Ying Wang, Yongtao Wang, Xiangyu Hou, Huichang Bi and Min Huang
      Drug Metabolism and Disposition September 2014, 42 (9) 1532-1539; DOI: https://doi.org/10.1124/dmd.114.059394

  4. Trauner, Michael

    1. Inflammatory Bowel Disease Alters Intestinal Bile Acid Transporter Expression
      Jörg Jahnel, Peter Fickert, Almuthe C. Hauer, Christoph Högenauer, Alexander Avian and Michael Trauner
      Drug Metabolism and Disposition September 2014, 42 (9) 1423-1431; DOI: https://doi.org/10.1124/dmd.114.058065

  5. Tweedie, Donald

    1. A Numerical Method for Analysis of In Vitro Time-Dependent Inhibition Data. Part 2. Application to Experimental Data
      Ken Korzekwa, Donald Tweedie, Upendra A. Argikar, Andrea Whitcher-Johnstone, Leslie Bell, Shari Bickford and Swati Nagar
      Drug Metabolism and Disposition September 2014, 42 (9) 1587-1595; DOI: https://doi.org/10.1124/dmd.114.058297

  6. Tyndale, Rachel F.

    1. Nicotine Pharmacokinetics in Rats Is Altered as a Function of Age, Impacting the Interpretation of Animal Model Data
      Evelyn L. Craig, Bin Zhao, Jason Z. Cui, Maria Novalen, Sharon Miksys and Rachel F. Tyndale
      Drug Metabolism and Disposition September 2014, 42 (9) 1447-1455; DOI: https://doi.org/10.1124/dmd.114.058719

U

  1. Uchida, Saeko

    1. A Strategy for Assessing Potential Drug-Drug Interactions of a Concomitant Agent against a Drug Absorbed via an Intestinal Transporter in Humans
      Akiko Mizuno-Yasuhira, Yasuhiro Nakai, Emi Gunji, Saeko Uchida, Teisuke Takahashi, Kohnosuke Kinoshita, Shigeji Jingu, Soichi Sakai, Yoshishige Samukawa and Jun-ichi Yamaguchi
      Drug Metabolism and Disposition September 2014, 42 (9) 1456-1465; DOI: https://doi.org/10.1124/dmd.114.058305

  2. Uehara, Shotaro

    1. Polymorphisms of CYP2D17 in Cynomolgus and Rhesus Macaques: an Evidence of the Genetic Basis for the Variability of CYP2D-Dependent Drug Metabolism
      Yasuhiro Uno, Shotaro Uehara, Sakae Kohara, Norie Murayama and Hiroshi Yamazaki
      Drug Metabolism and Disposition September 2014, 42 (9) 1407-1410; DOI: https://doi.org/10.1124/dmd.114.059220

  3. Ullah, Mohammed

    1. Calibration of In Vitro Multidrug Resistance Protein 1 Substrate and Inhibition Assays as a Basis to Support the Prediction of Clinically Relevant Interactions In Vivo
      Agnès Poirier, Anne-Christine Cascais, Urs Bader, Renée Portmann, Marie-Elise Brun, Isabelle Walter, Alexander Hillebrecht, Mohammed Ullah and Christoph Funk
      Drug Metabolism and Disposition September 2014, 42 (9) 1411-1422; DOI: https://doi.org/10.1124/dmd.114.057943
    2. The Need for Human Breast Cancer Resistance Protein Substrate and Inhibition Evaluation in Drug Discovery and Development: Why, When, and How?
      Agnès Poirier, Renée Portmann, Anne-Christine Cascais, Urs Bader, Isabelle Walter, Mohammed Ullah and Christoph Funk
      Drug Metabolism and Disposition September 2014, 42 (9) 1466-1477; DOI: https://doi.org/10.1124/dmd.114.058248

  4. Uno, Yasuhiro

    1. Polymorphisms of CYP2D17 in Cynomolgus and Rhesus Macaques: an Evidence of the Genetic Basis for the Variability of CYP2D-Dependent Drug Metabolism
      Yasuhiro Uno, Shotaro Uehara, Sakae Kohara, Norie Murayama and Hiroshi Yamazaki
      Drug Metabolism and Disposition September 2014, 42 (9) 1407-1410; DOI: https://doi.org/10.1124/dmd.114.059220

V

  1. Van Le, Thi Kim

    1. Gut Microbiota-Mediated Drug Interactions between Lovastatin and Antibiotics
      Dae-Hyoung Yoo, In Sook Kim, Thi Kim Van Le, Il-Hoon Jung, Hye Hyun Yoo and Dong-Hyun Kim
      Drug Metabolism and Disposition September 2014, 42 (9) 1508-1513; DOI: https://doi.org/10.1124/dmd.114.058354

W

  1. Walter, Isabelle

    1. Calibration of In Vitro Multidrug Resistance Protein 1 Substrate and Inhibition Assays as a Basis to Support the Prediction of Clinically Relevant Interactions In Vivo
      Agnès Poirier, Anne-Christine Cascais, Urs Bader, Renée Portmann, Marie-Elise Brun, Isabelle Walter, Alexander Hillebrecht, Mohammed Ullah and Christoph Funk
      Drug Metabolism and Disposition September 2014, 42 (9) 1411-1422; DOI: https://doi.org/10.1124/dmd.114.057943
    2. The Need for Human Breast Cancer Resistance Protein Substrate and Inhibition Evaluation in Drug Discovery and Development: Why, When, and How?
      Agnès Poirier, Renée Portmann, Anne-Christine Cascais, Urs Bader, Isabelle Walter, Mohammed Ullah and Christoph Funk
      Drug Metabolism and Disposition September 2014, 42 (9) 1466-1477; DOI: https://doi.org/10.1124/dmd.114.058248

  2. Wang, Xiaodong

    1. Flavonoids Are Inhibitors of Human Organic Anion Transporter 1 (OAT1)–Mediated Transport
      Guohua An, Xiaodong Wang and Marilyn E. Morris
      Drug Metabolism and Disposition September 2014, 42 (9) 1357-1366; DOI: https://doi.org/10.1124/dmd.114.059337

  3. Wang, Ying

    1. Dynamic and Coordinated Regulation of KEAP1-NRF2-ARE and p53/p21 Signaling Pathways Is Associated with Acetaminophen Injury Responsive Liver Regeneration
      Xiaomei Fan, Pan Chen, Huasen Tan, Hang Zeng, Yiming Jiang, Ying Wang, Yongtao Wang, Xiangyu Hou, Huichang Bi and Min Huang
      Drug Metabolism and Disposition September 2014, 42 (9) 1532-1539; DOI: https://doi.org/10.1124/dmd.114.059394

  4. Wang, Yongtao

    1. Dynamic and Coordinated Regulation of KEAP1-NRF2-ARE and p53/p21 Signaling Pathways Is Associated with Acetaminophen Injury Responsive Liver Regeneration
      Xiaomei Fan, Pan Chen, Huasen Tan, Hang Zeng, Yiming Jiang, Ying Wang, Yongtao Wang, Xiangyu Hou, Huichang Bi and Min Huang
      Drug Metabolism and Disposition September 2014, 42 (9) 1532-1539; DOI: https://doi.org/10.1124/dmd.114.059394

  5. Whitcher-Johnstone, Andrea

    1. A Numerical Method for Analysis of In Vitro Time-Dependent Inhibition Data. Part 2. Application to Experimental Data
      Ken Korzekwa, Donald Tweedie, Upendra A. Argikar, Andrea Whitcher-Johnstone, Leslie Bell, Shari Bickford and Swati Nagar
      Drug Metabolism and Disposition September 2014, 42 (9) 1587-1595; DOI: https://doi.org/10.1124/dmd.114.058297

X

  1. Xiao, Deqing

    1. Evaluation of Calibration Curve–Based Approaches to Predict Clinical Inducers and Noninducers of CYP3A4 with Plated Human Hepatocytes
      J. George Zhang, Thuy Ho, Alanna L. Callendrello, Robert J. Clark, Elizabeth A. Santone, Sarah Kinsman, Deqing Xiao, Lisa G. Fox, Heidi J. Einolf and David M. Stresser
      Drug Metabolism and Disposition September 2014, 42 (9) 1379-1391; DOI: https://doi.org/10.1124/dmd.114.058602

Y

  1. Yamada, Hideyuki

    1. Effect of CYP2A6 Genetic Polymorphism on the Metabolic Conversion of Tegafur to 5-Fluorouracil and Its Enantioselectivity
      Ikuo Yamamiya, Kunihiro Yoshisue, Yuji Ishii, Hideyuki Yamada and Masato Chiba
      Drug Metabolism and Disposition September 2014, 42 (9) 1485-1492; DOI: https://doi.org/10.1124/dmd.114.058008
    2. A Useful Model Capable of Predicting the Clearance of Cytochrome P450 3A4 (CYP3A4) Substrates in Humans: Validity of CYP3A4 Transgenic Mice Lacking Their Own Cyp3a Enzymes
      Tetsuya Mitsui, Takayuki Nemoto, Taiji Miyake, Shunsuke Nagao, Kotaro Ogawa, Motohiro Kato, Masaki Ishigai and Hideyuki Yamada
      Drug Metabolism and Disposition September 2014, 42 (9) 1540-1547; DOI: https://doi.org/10.1124/dmd.114.057935

  2. Yamaguchi, Jun-ichi

    1. A Strategy for Assessing Potential Drug-Drug Interactions of a Concomitant Agent against a Drug Absorbed via an Intestinal Transporter in Humans
      Akiko Mizuno-Yasuhira, Yasuhiro Nakai, Emi Gunji, Saeko Uchida, Teisuke Takahashi, Kohnosuke Kinoshita, Shigeji Jingu, Soichi Sakai, Yoshishige Samukawa and Jun-ichi Yamaguchi
      Drug Metabolism and Disposition September 2014, 42 (9) 1456-1465; DOI: https://doi.org/10.1124/dmd.114.058305

  3. Yamamiya, Ikuo

    1. Effect of CYP2A6 Genetic Polymorphism on the Metabolic Conversion of Tegafur to 5-Fluorouracil and Its Enantioselectivity
      Ikuo Yamamiya, Kunihiro Yoshisue, Yuji Ishii, Hideyuki Yamada and Masato Chiba
      Drug Metabolism and Disposition September 2014, 42 (9) 1485-1492; DOI: https://doi.org/10.1124/dmd.114.058008

  4. Yamazaki, Hiroshi

    1. Polymorphisms of CYP2D17 in Cynomolgus and Rhesus Macaques: an Evidence of the Genetic Basis for the Variability of CYP2D-Dependent Drug Metabolism
      Yasuhiro Uno, Shotaro Uehara, Sakae Kohara, Norie Murayama and Hiroshi Yamazaki
      Drug Metabolism and Disposition September 2014, 42 (9) 1407-1410; DOI: https://doi.org/10.1124/dmd.114.059220

  5. Yoo, Dae-Hyoung

    1. Gut Microbiota-Mediated Drug Interactions between Lovastatin and Antibiotics
      Dae-Hyoung Yoo, In Sook Kim, Thi Kim Van Le, Il-Hoon Jung, Hye Hyun Yoo and Dong-Hyun Kim
      Drug Metabolism and Disposition September 2014, 42 (9) 1508-1513; DOI: https://doi.org/10.1124/dmd.114.058354

  6. Yoo, Hye Hyun

    1. Gut Microbiota-Mediated Drug Interactions between Lovastatin and Antibiotics
      Dae-Hyoung Yoo, In Sook Kim, Thi Kim Van Le, Il-Hoon Jung, Hye Hyun Yoo and Dong-Hyun Kim
      Drug Metabolism and Disposition September 2014, 42 (9) 1508-1513; DOI: https://doi.org/10.1124/dmd.114.058354

  7. Yoshisue, Kunihiro

    1. Effect of CYP2A6 Genetic Polymorphism on the Metabolic Conversion of Tegafur to 5-Fluorouracil and Its Enantioselectivity
      Ikuo Yamamiya, Kunihiro Yoshisue, Yuji Ishii, Hideyuki Yamada and Masato Chiba
      Drug Metabolism and Disposition September 2014, 42 (9) 1485-1492; DOI: https://doi.org/10.1124/dmd.114.058008

  8. Yun, Chul-Ho

    1. Regioselective Hydroxylation of Omeprazole Enantiomers by Bacterial CYP102A1 Mutants
      Sang Hoon Ryu, Bo-Yeon Park, So-Young Kim, Sun-Ha Park, Hyun-Jin Jung, Min Park, Ki Deok Park, Taeho Ahn, Hyung-Sik Kang and Chul-Ho Yun
      Drug Metabolism and Disposition September 2014, 42 (9) 1493-1497; DOI: https://doi.org/10.1124/dmd.114.058636

Z

  1. Zeng, Hang

    1. Dynamic and Coordinated Regulation of KEAP1-NRF2-ARE and p53/p21 Signaling Pathways Is Associated with Acetaminophen Injury Responsive Liver Regeneration
      Xiaomei Fan, Pan Chen, Huasen Tan, Hang Zeng, Yiming Jiang, Ying Wang, Yongtao Wang, Xiangyu Hou, Huichang Bi and Min Huang
      Drug Metabolism and Disposition September 2014, 42 (9) 1532-1539; DOI: https://doi.org/10.1124/dmd.114.059394

  2. Zhang, J. George

    1. Evaluation of Calibration Curve–Based Approaches to Predict Clinical Inducers and Noninducers of CYP3A4 with Plated Human Hepatocytes
      J. George Zhang, Thuy Ho, Alanna L. Callendrello, Robert J. Clark, Elizabeth A. Santone, Sarah Kinsman, Deqing Xiao, Lisa G. Fox, Heidi J. Einolf and David M. Stresser
      Drug Metabolism and Disposition September 2014, 42 (9) 1379-1391; DOI: https://doi.org/10.1124/dmd.114.058602

  3. Zhao, Bin

    1. Nicotine Pharmacokinetics in Rats Is Altered as a Function of Age, Impacting the Interpretation of Animal Model Data
      Evelyn L. Craig, Bin Zhao, Jason Z. Cui, Maria Novalen, Sharon Miksys and Rachel F. Tyndale
      Drug Metabolism and Disposition September 2014, 42 (9) 1447-1455; DOI: https://doi.org/10.1124/dmd.114.058719
Back to top

In this issue